Bank of New York Mellon Corp
BankPosition in SPRY — ARS Pharmaceuticals, Inc.
CIK 1390777
NEW YORK, NY
Position in SPRY
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,317,432
-$581,586 QoQ
Shares Held
164,064
+0.6% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. SPRY ranks #157 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in SPRY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,317,432 | 164,064 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,899,018 | 163,006 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,553,769 | 154,604 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,532,290 | 145,117 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,663,238 | 132,213 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,374,009 | 130,238 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,908,358 | 131,611 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,185,315 | 139,285 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $714,284 | 69,891 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $462,281 | 84,358 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $317,232 | 83,924 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $515,229 | 76,900 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $98,853 | 15,185 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $129,527 | 15,185 | Shares | Defined | 2023-02-14 | |
| 2022-03-31 | $205,839 | 58,644 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $400,005 | 60,061 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $565,545 | 56,668 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $1,221,514 | 39,544 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,518,846 | 34,812 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||